Health Pfizer Says Its Vaccine Is More Than 90% Effective in Preventing COVID in Kids Aged 5 to 11

01:10  23 october  2021
01:10  23 october  2021 Source:   people.com

20 climate-damaging foods

  20 climate-damaging foods With the recent news that humankind has just 11 years to “stop catastrophic climate change,” many are seeking ways to do their part and diet is a great place to start, given that “food production is responsible for a quarter of all greenhouse gas emissions.” If you’re looking to help the environment, consider reducing your consumption of these 20 climate-damaging foods.

Pfizer's COVID-19 vaccine is highly effective in kids aged 5 to 11, the company said Friday, reporting that it prevented any symptoms of the virus 90.7% of the time.

Getty A child getting vaccinated © Provided by People Getty A child getting vaccinated

The company submitted data from their clinical trials to the Food and Drug Administration ahead of the federal health agency's meeting on Tuesday, where a group of outside advisors will consider Pfizer's request to grant emergency use authorization for their vaccine in that age group.

Pfizer had studied the effectiveness of two 10 microgram doses, given 21 days apart, of their vaccine in children aged 5 to 11, which is a third of the size of the dose given to adults and kids in the next age group up, those 12 to 18. The researchers said that the dosage was safe for the age group and chosen to reduce side effects while still creating a strong immune response.

The COVID vaccine for kids 5 to 11 years: What parents need to know

  The COVID vaccine for kids 5 to 11 years: What parents need to know If you have a school-aged child, it's almost their turn for a COVID-19 vaccination, and you may have questions. Here are the answers.But now that it’s almost time for younger kids the get the COVID-19 vaccine, parents have questions. Here are some answers.

RELATED: With Smaller Doses and Needles, Biden Administration Lays Out Plan to Vaccinate Kids 5 to 11

Of the 2,268 kids in the trial, 16 kids who received a placebo contracted COVID-19, compared to just three who had the vaccine. No one in the trial developed a severe illness, and the only cases that occurred were in July or after, when the more contagious delta variant was dominant in the U.S.

There were no safety issues during the trial, the company said, and no cases of myocarditis, or heart inflammation. However, the trial was likely too small and the condition too rare for any to turn up.

If the FDA and CDC decide to authorize Pfizer's vaccine, it would be the first COVID-19 vaccine available for young kids.

RELATED VIDEO: FDA Grants Full Approval to Pfizer's COVID Vaccine

The booster debate: Will you need a third COVID-19 shot?

  The booster debate: Will you need a third COVID-19 shot? Questions on booster shots are dividing scientists. Who needs a third shot of the COVID-19 vaccine? And when might they need it? WATCH: Antibodies only half the story of vaccine protection: experts Your browser does not support this video Finzi and Kaufmann’s teams are following a small group of healthcare workers, just over 40, half of whom were previously infected with COVID-19, the other having never encountered the virus — all of whom received two doses of the Pfizer-BioNTech vaccine. Their findings show the vaccine produces a robust immune response and is holding up against infections.

The Biden administration said Wednesday that as soon as the vaccine is approved for use, they will make it available at more than 25,000 pediatrician offices and primary care facilities, more than 100 children's hospitals and at pharmacies and schools. The White House said that have purchased enough doses to inoculate the 28 million kids in that age group in the U.S.

Though children are at a lower risk of severe disease and hospitalization from COVID-19, they can still get sick and pass the virus on to others. More children have been hospitalized since the emergence of the delta variant, and currently, children are testing positive for COVID-19 at a disproportionately high rate. During the week of Oct. 14, those 18 and younger accounted for 25.5% of all cases in the U.S., according to the American Academy of Pediatrics, despite making up just 22.2% of the total population.

"Millions of adolescents ages 12-17 have been safely vaccinated, and we know vaccines work," the White House said. "Fully vaccinated individuals are 10 times less likely to be hospitalized with COVID-19 and have a high degree of protection, including against the Delta variant. The consequences of a pediatric COVID-19 case can be serious and potentially last months."

If You Got Moderna or J&J, Dr. Fauci Says Here's the Latest on Boosters

  If You Got Moderna or J&J, Dr. Fauci Says Here's the Latest on Boosters The Pfizer COVID vaccine has been fully authorized by the FDA; the Moderna and J&J shots still have emergency use approval.

As information about the coronavirus pandemic rapidly changes, PEOPLE is committed to providing the most recent data in our coverage. Some of the information in this story may have changed after publication. For the latest on COVID-19, readers are encouraged to use online resources from the CDC, WHO and local public health departments. PEOPLE has partnered with GoFundMe to raise money for the COVID-19 Relief Fund, a GoFundMe.org fundraiser to support everything from frontline responders to families in need, as well as organizations helping communities. For more information or to donate, click here.

A child getting vaccinated © Getty A child getting vaccinated

Your kid is about to be eligible to get a COVID-19 vaccine in Manitoba. Now what? .
Here's a look at what we know so far about how Manitoba's vaccine rollout will work for some of the youngest residents.But parents of five- to 11-year-olds might still have some questions about when the shots will be available, where their children will be able to get them and why they need to get immunized in the first place.

usr: 1
This is interesting!